Impact on 30-d readmissions for cirrhotic patients with ascites after an educational intervention: A pilot study

doi:10.4254/wjh.v11.i10.701

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4403)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

250

WORD

188

HTML

1742

Tables (1-4)

177

Sum=2357

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

700

Download

1346

Sum=2046

Oct 27, 2019 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Oct 27, 2019; 11(10): 701-709
Published online Oct 27, 2019. doi: 10.4254/wjh.v11.i10.701

Table 2 Baseline characteristics, n (%)

Groups	Control (n = 39)	Intervention (n = 46)	P value
Female	18 (46.2)	19 (41.3)	0.7
Age, yr	51.9 (11.4)	54.9 (10.9)	0.2
Hepatology consult	22 (56.41)	30 (65.22)	0.4
MELD-Na score	25.5 (6.2)	26.1 (7.7)	0.7
Comorbidities
CAD	3 (7.69)	4 (8.7)	0.9
CKD	25 (64.1)	39 (84.78)	0.03
DM	11 (28.21)	17 (36.96)	0.4
HD	11 (28.21)	16 (34.78)	0.5
HIV	3 (7.69)	0 (0)	0.06
PVT	5 (12.82)	6 (13.04)	1
Etiology of cirrhosis			0.3
ETOH	23 (58.97)	21 (45.65)
Hepatitis C	1 (2.56)	5 (10.87)
ETOH/Hep C	3 (7.69)	2 (4.35)
Hepatitis B	3 (7.69)	1 (2.17)
NASH	4 (10.26)	8 (17.39)
Other	5 (12.82)	9 (19.57)

MELD-Na: Model of end-stage liver disease-sodium; CAD: Coronary artery disease; CKD: Chronic kidney disease; DM: Diabetes mellitus; HD: Hemodialysis; HIV: Human immunodeficiency virus; PVT: Portal vein thrombosis; ETOH: Alcohol; NASH: Non-alcoholic steatohepatitis.

Citation: Lim N, Sanchez O, Olson A. Impact on 30-d readmissions for cirrhotic patients with ascites after an educational intervention: A pilot study. World J Hepatol 2019; 11(10): 701-709
URL: https://www.wjgnet.com/1948-5182/full/v11/i10/701.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i10.701